Crohn's Disease Clinical Trials in Minneapolis, Minnesota

3 studies are recruiting for crohn's disease in Minneapolis, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

    Crohn's Disease (CD) is a gastrointestinal disease that can cause chronic diarrhea with or without gross bleeding, abdominal pain, weight loss, and fever. This study will assess the pharmacokinetics, efficacy, and safety of risankizumab in pediatric participants with moderately to severely active C…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    MNGI Digestive Health, P. A. /ID# 255366, Minneapolis, Minnesota
    Locations
    85 in total
    Run by
    AbbVie

    See if you can join NCT05995353 on ClinicalTrials.gov

  2. Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

    Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the bowels. It can cause many different symptoms including abdominal pain, diarrhea, tiredness, and weight loss. This study will assess how safe and effec…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    MNGI Digestive Health, P. A. /ID# 262204, Minneapolis, Minnesota
    Locations
    85 in total
    Run by
    AbbVie

    See if you can join NCT06332534 on ClinicalTrials.gov

  3. A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

    The study is an extension of two parent studies (MLN0002-3024 [NCT04779307] and MLN0002-3025 [NCT04779320]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.

    Stage
    Phase 3
    Ages
    2 and older
    Site
    MNGI Digestive Health PA-Plymouth, Minneapolis, Minnesota
    Locations
    98 in total
    Run by
    Takeda

    See if you can join NCT05442567 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.